Jim Simons In Med Pharmaceuticals Inc. Call Options Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INM
# of Institutions
15Shares Held
1.12MCall Options Held
0Put Options Held
0-
Advisor Shares Investments LLC Bethesda, MD733KShares$2.83 Million0.03% of portfolio
-
Ubs Group Ag212KShares$818,4700.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il56.7KShares$218,7300.0% of portfolio
-
Hrt Financial LP New York, NY38.4KShares$148,1040.0% of portfolio
-
Virtu Financial LLC New York, NY28.4KShares$109,6810.0% of portfolio
About InMed Pharmaceuticals Inc.
- Ticker INM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 908,761
- Market Cap $3.51M
- Description
- InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...